pp 1-10 | Cite as

Human Synovium-Derived Mesenchymal Stem Cells: Ex Vivo Analysis

  • Janja ZupanEmail author
Part of the Methods in Molecular Biology book series


Synovium-derived mesenchymal stem/stromal cells (MSCs) have been shown to have superior features in comparison with MSCs from other tissue sources. As they are far less recognised compared to bone marrow- or adipose tissue-derived MSCs, I provide here a detailed procedure on how to isolate MSCs from human synovium. This includes determination of the proportions of viable cells in ex vivo isolated fractions before the seeding of the cells and a description of how to carry out colony-forming fibroblast assays to quantify the clonogenicity of these cells.


Colony-forming unit fibroblast assay Human Isolation Mesenchymal stem/stromal cells Synovium 



Janja Zupan was funded by UK Arthritis Research in 2016–2018 and is currently part of the P3-0298 Research Programme ‘Genes, hormones and personality changes in metabolic disorders’, funded by the Slovenian Research Agency.


  1. 1.
    Sakaguchi Y, Sekiya I, Yagishita K et al (2005) Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 52:2521–2529Google Scholar
  2. 2.
    De BC, Dell’Accio F, Tylzanowski P et al (2001) Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44:1928–1942Google Scholar
  3. 3.
    Kurth TB, Dell’Accio F, Crouch V et al (2011) Functional mesenchymal stem cell niches in adult mouse knee joint synovium in vivo. Arthritis Rheum 63:1289–1300. Scholar
  4. 4.
    Roelofs AJ, Zupan J, Riemen AHK et al (2017) Joint morphogenetic cells in the adult mammalian synovium. Nat Commun 8:15040. Scholar
  5. 5.
    De Bari C, Roelofs AJ (2018) Stem cell-based therapeutic strategies for cartilage defects and osteoarthritis. Curr Opin Pharmacol 40:74–80. Scholar
  6. 6.
    Murata Y, Uchida S, Utsunomiya H et al (2018) Synovial mesenchymal stem cells derived from the cotyloid fossa synovium have higher self-renewal and differentiation potential than those from the paralabral synovium in the hip joint. Am J Sports Med 14:1–2. Scholar
  7. 7.
    Dominici M, Le BK, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317Google Scholar
  8. 8.
    Sacchetti B, Funari A, Remoli C et al (2016) No identical ‘mesenchymal stem cells’ at different times and sites: human committed progenitors of distinct origin and differentiation potential are incorporated as adventitial cells in microvessels. Stem Cell Reports 6:897–913. Scholar
  9. 9.
    de SE, Casado P, Neto V et al (2014) Synovial fluid and synovial membrane mesenchymal stem cells: latest discoveries and therapeutic perspectives. Stem Cell Res Ther 5:112. Scholar
  10. 10.
    Hermida-Gómez T, Fuentes-Boquete I, Gimeno-Longas MJ et al (2011) Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes. J Rheumatol 38:339–349. Scholar
  11. 11.
    De Bari C, Dell’Accio F, Karystinou A et al (2008) A biomarker-based mathematical model to predict bone-forming potency of human synovial and periosteal mesenchymal stem cells. Arthritis Rheum 58:240–250. Scholar
  12. 12.
    Čamernik K, Barlič A, Drobnič M et al (2018) Mesenchymal stem cells in the musculoskeletal system: from animal models to human tissue regeneration? Stem Cell Rev 14(3):346–369. Scholar
  13. 13.
    Tsai C-C, Yew T-L, Yang D-C et al (2012) Benefits of hypoxic culture on bone marrow multipotent stromal cells. Am J Blood Res 2:148–159Google Scholar

Copyright information

© Springer Science+Business Media New York 2018

Authors and Affiliations

  1. 1.Faculty of Pharmacy, Department of Clinical BiochemistryUniversity of LjubljanaLjubljanaSlovenia

Personalised recommendations